8/26/24 17:05 | 8/22/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Harrington Michael J | IN | D | | P | 52 | 14.85 | 0 | 4 | 5 | 81 | D | | | | | | | | | | | | | | |
8/13/24 09:04 | 8/12/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Simmons Jeffrey N | IN | DO | P,CEO,Di | P | 1,301 | 13.01 | 0 | 100 | 7 | 1,503 | I | | | | | | | | | | | | | | |
5/23/24 16:33 | 5/21/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Doyle William F | IN | D | | P | 255 | 16.98 | 0 | 15 | 24 | 76 | D | | | | | | | | | | | | | | |
3/12/24 16:32 | 3/8/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Doyle William F | IN | D | | P | 245 | 16.30 | 0 | 15 | 32 | 61 | D | | | | | | | | | | | | | | |
3/12/24 16:30 | 3/8/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Harrington Michael J | IN | D | | P | 50 | 16.29 | 0 | 3 | 4 | 78 | D | | | | | | | | | | | | | | |
3/8/24 17:09 | 3/6/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | | P | 323 | 16.14 | 0 | 20 | 8 | 279 | I | | | | | | | | | | | | | | |
3/15/23 16:21 | 3/13/23 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | | P.m | 95 | 9.50 | 0 | 10 | 4 | 239 | I | | | | | | | | | | | | | | |
3/13/23 16:08 | 3/10/23 | ELAN | Health | Drug | Pharmaceutical Preparations | Simmons Jeffrey N | IN | DO | P,CEO,Di | P | 144 | 9.60 | 0 | 15 | 1 | 1,188 | I | | | | | | | | | | | | | | |
3/7/23 17:47 | 3/3/23 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | | P | 111 | 11.13 | 0 | 10 | 5 | 229 | I | | | | | | | | | | | | | | |
11/15/22 16:40 | 11/11/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Bilbrey John P | IN | D | | P | 99 | 13.24 | 0 | 8 | 14 | 63 | I | | | | | | | | | | | | | | |
9/9/22 16:31 | 9/9/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | | P | 304 | 15.18 | 0 | 20 | 11 | 200 | I | | | | | | | | | | | | | | |
9/9/22 16:30 | 9/9/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Simmons Jeffrey N | IN | DO | P,CEO,Di | P | 436 | 14.54 | 0 | 30 | 4 | 783 | I | | | | | | | | | | | | | | |
9/9/22 16:29 | 9/9/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Modi Rajeev A. | IN | O | SEE REMA | P | 100 | 14.90 | 0 | 7 | 19 | 41 | D | | | | | | | | | | | | | | |
9/9/22 16:29 | 9/9/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Herendeen Paul | IN | D | | P | 150 | 15.03 | 0 | 10 | 137 | 17 | D | | | | | | | | | | | | | | |
5/24/22 16:33 | 5/20/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | | P | 233 | 23.33 | 0 | 10 | 6 | 180 | I | | | | | | | | | | | | | | |
5/13/22 17:59 | 5/11/22 | ELAN | Health | Drug | Pharmaceutical Preparations | Bilbrey John P | IN | D | | P | 220 | 22.03 | 0 | 10 | 22 | 55 | I | | | | | | | | | | | | | | |